TD Cowen 46th Annual Health Care Conference March 2, 2026 9:50 AM ESTCompany ParticipantsScott Ullem - Corporate ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM ESTCompany ParticipantsChristopher Viehbacher - President, CEO ...
Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic ...
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines to treat brain disorders and symptoms caused by excess neural ...
Tardive dyskinesia (TD) is a challenging movement disorder caused primarily by the use of medications. For sufferers of TD, the symptoms and signs are all too clear and all too problematic at the ...
Tic disorders are childhood-onset neuropsychiatric conditions that frequently co-occur with allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis. This narrative review maps ...
NEW YORK, NEW YORK - OCTOBER 11: A branch of the Canadian based TD bank, on the morning they plead guilty to money laundering, the largest bank in United States history to do so, on October 11, 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results